skip to Main Content

Promoting Interventions for Viral Hepatitis and Harm Reduction in COP 2022

On February 3rd, 2022, TAG, in collaboration with the International Network of People who Use Drugs (INPUD), Harm Reduction International (HRI), and the World Hepatitis Alliance (WHA), hosted a free webinar, “Promoting Interventions for Viral Hepatitis and Harm Reduction in COP 2022.” The webinar focused on how to integrate viral hepatitis programming and harm reduction into COP guidance, to more effectively engage people who inject drugs.

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is the largest source of funding for the HIV response globally. It is critical that these funds meet the needs of all people living with and affected by HIV and viral hepatitis, particularly people who inject drugs, who are disproportionately affected and excluded from care. PEPFAR Watch brings together activists ahead of the Country Operational Plan (COP) planning process to develop priority recommendations and community demands for PEPFAR.

Facilitator
Hilary McQuie, Treatment Action Group

Speakers
Prioritizing Hepatitis C Virus (HCV) in PEPFAR COP 2022 – Joelle Dountio Ofimboudem, Treatment Action Group
Hepatitis B Integration for PEPFAR — Danjuma Adda, World Hepatitis Alliance
Drug Use in African PEPFAR-Recipient Countries: What Do We Know? — Maria-Goretti Loglo, International Drug Policy Consortium
Where Does PEPFAR Stand on People Who Use Drugs: Recommendations For and By People Who Use Drugs – Aditia Taslim, International Network of People who Use Drugs
Failure to Fund –  Colleen Daniels, Harm Reduction International

Video recordings of the full webinar in English and Portuguese are below.

Back To Top